References
- ZhaoXLiuLLiKLiWZhaoLZouHComparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysisOnco Targets Ther201582721273026491345
- AdesAECaldwellDMRekenSWeltonNJSuttonAJDiasSEvidence synthesis for decision making 7: a reviewer’s checklistMed Decis Making201333567969123804511
- BonneterreJThurlimannBRobertsonJFAnastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex randomized group efficacy and tolerability studyJ Clin Oncol200018223748375711078487
- NabholtzJMBuzdarAPollakMAnastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study GroupJ Clin Oncol200018223758376711078488
- ParidaensRJDirixLYBeexLVPhase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupJ Clin Oncol200826304883489018794551